Jins.Cm

JINS.CM maintains a liquidity position with a debt-to-equity ratio of 0.13, indicating a relatively low leverage profile. The company's free cash flow is negative at -33.325 million, while operating cash flow stands at 460.342 million, suggesting that capital expenditures are consuming a portion of its operating cash. The company's total assets amount to 40.366 billion, supported by total equity of 16.644 billion.

In terms of profitability, JINS.CM reports a return on equity (ROE) of 20.83% and a return on assets (ROA) of 8.59%, both of which are strong indicators of efficient capital utilization and asset management. These figures suggest that the company is generating substantial returns relative to its equity and asset base, which is favorable compared to industry norms.

The company's revenue is primarily derived from its insurance and asset management operations, with no specific geographic concentration disclosed in the available data. However, the absence of detailed segment or geographic breakdowns limits the ability to assess exposure to specific markets or product lines.

Looking at growth, JINS.CM has demonstrated a positive operating income of 2.149 billion and a net income of 3.466 billion. While the company's capital expenditures are significant at -308.885 million, the overall financial performance indicates a stable and growing business. The outlook for the current fiscal year is positive, with the company likely to maintain its profitability and asset management efficiency.

Risk factors for JINS.CM include a medium liquidity risk, as indicated by the risk assessment, and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose a challenge in maintaining liquidity under adverse market conditions. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, preserving shareholder value.

Recent events and filings have not been disclosed in the available data, so no specific recent developments can be cited. The company's financial health and operational performance remain the primary focus of the current analysis.